EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 109 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $68,779 | -60.6% | 3,538 | -42.5% | 0.00% | -100.0% |
Q1 2023 | $174,646 | +71476.2% | 6,156 | -26.2% | 0.00% | 0.0% |
Q4 2022 | $244 | +15.1% | 8,345 | +4.1% | 0.00% | 0.0% |
Q3 2022 | $212 | -99.9% | 8,017 | +5.1% | 0.00% | -50.0% |
Q2 2022 | $339,000 | -11.0% | 7,627 | -0.8% | 0.00% | +100.0% |
Q1 2022 | $381,000 | +6.1% | 7,691 | +9.2% | 0.00% | 0.0% |
Q4 2021 | $359,000 | -3.2% | 7,046 | +6.1% | 0.00% | 0.0% |
Q3 2021 | $371,000 | +23.3% | 6,639 | -5.7% | 0.00% | 0.0% |
Q2 2021 | $301,000 | +2.0% | 7,037 | -0.4% | 0.00% | 0.0% |
Q1 2021 | $295,000 | -4.8% | 7,064 | +6.1% | 0.00% | 0.0% |
Q4 2020 | $310,000 | +20.2% | 6,660 | +9.3% | 0.00% | 0.0% |
Q3 2020 | $258,000 | -11.6% | 6,091 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $292,000 | -3.9% | 6,091 | -7.9% | 0.00% | -50.0% |
Q1 2020 | $304,000 | -27.4% | 6,615 | -5.1% | 0.00% | 0.0% |
Q4 2019 | $419,000 | -8.5% | 6,970 | -13.9% | 0.00% | 0.0% |
Q3 2019 | $458,000 | +9.0% | 8,098 | +7.3% | 0.00% | 0.0% |
Q2 2019 | $420,000 | +8.0% | 7,546 | -2.0% | 0.00% | 0.0% |
Q1 2019 | $389,000 | +21.9% | 7,701 | -2.6% | 0.00% | 0.0% |
Q4 2018 | $319,000 | -23.7% | 7,910 | +31.2% | 0.00% | 0.0% |
Q3 2018 | $418,000 | -4.3% | 6,031 | +4.4% | 0.00% | 0.0% |
Q2 2018 | $437,000 | +38.7% | 5,778 | -3.4% | 0.00% | 0.0% |
Q1 2018 | $315,000 | -7.1% | 5,980 | -5.8% | 0.00% | 0.0% |
Q4 2017 | $339,000 | -19.3% | 6,349 | -9.8% | 0.00% | 0.0% |
Q3 2017 | $420,000 | -28.8% | 7,040 | -5.9% | 0.00% | -33.3% |
Q2 2017 | $590,000 | -5.0% | 7,485 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $621,000 | +23.2% | 7,485 | +17.8% | 0.00% | 0.0% |
Q4 2016 | $504,000 | +13.3% | 6,355 | 0.0% | 0.00% | +50.0% |
Q3 2016 | $445,000 | – | 6,355 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ProQuest Associates IV LLC | 3,652,284 | $302,920,000 | 91.10% |
Hudson Executive Capital LP | 1,901,200 | $157,686,000 | 21.62% |
JW Asset Management, LLC | 525,755 | $43,606,000 | 9.08% |
Cormorant Asset Management, LP | 200,000 | $16,588,000 | 2.41% |
Park West Asset Management LLC | 488,128 | $40,485,000 | 2.36% |
Opaleye Management Inc. | 50,000 | $4,147,000 | 2.06% |
Ranger Investment Management | 283,954 | $23,551,000 | 1.71% |
Pier Capital, LLC | 74,732 | $6,198,000 | 1.06% |
Bellevue Group AG | 67,700 | $5,615,000 | 0.75% |
Orbimed Advisors | 671,000 | $55,653,000 | 0.63% |